EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

The Silkworm Carboxypeptidase Inhibitor Prevents Gastric Cancer Cells’ Proliferation through the EGF/EGFR Signaling Pathway

Junhong Ye iD, Jifu Li, Ping Zhao

International Journal of Molecular Sciences · 2023

DOI: 10.3390/ijms24021078 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2023. Verfasst von Junhong Ye und 2 weiteren Autor:innen. Beteiligte Einrichtung: State Key Laboratory of Silkworm Genome Biology, Biological Science Research Center, Southwest University, Chongqing 400716, China. Hauptthemen laut MEDLINE: Bombyx, Stomach Neoplasms, Antineoplastic Agents. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 59 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China, Chongqing Natural Science Foundation for Innovation Group Science Foundation.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Gastric cancer is a common malignant tumor originating from the gastric mucosa epithelium. Studies have shown that bioactive substances such as antimicrobial peptides and cantharidin contained in a variety of insects can exert anti-cancer functions; when compared with chemotherapy drugs, these bioactive substances have less toxicity and reduced side effects. Here, we report the first Bombyx mori carboxypeptidase inhibitor that is specifically and highly expressed in silk glands, which can significantly prevent the proliferation of gastric cancer cells by inhibiting the MAPK/ERK pathway initiated by EGF/EGFR through the promotion of expression of the proto-oncogene c-Myc, thereby affecting the expression of related cyclins. Through molecular docking and virtual screening of silkworm carboxypeptidase inhibitors and epidermal growth factor receptors, we identified a polypeptide that overlapped with existing small-molecule inhibitors of the receptor. In the present work, we explore the medicinal potential and application of silkworm carboxypeptidase inhibitors to promote the development of anti-tumor drugs from insect-derived substances.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

BombyxStomach NeoplasmsAntineoplastic AgentsAnimalsHumansEpidermal Growth FactorMolecular Docking SimulationSignal TransductionErbB ReceptorsCell ProliferationCarboxypeptidases

Stichwörter der Autor:innen

anti-tumor activitycarboxypeptidase inhibitorgastric cancersilkworm

Substanzen

Epidermal Growth FactorErbB ReceptorsAntineoplastic AgentsCarboxypeptidasesEGFR protein, human

Autor:innen und Institutionen

  • State Key Laboratory of Silkworm Genome Biology, Biological Science Research Center, Southwest University, Chongqing 400716, China.
  • College of Sericulture, Textile and Biomass Sciences, Southwest University, Chongqing 400716, China.

ORCID-Profile: Junhong Ye

Förderung

  • National Natural Science Foundation of China
  • Chongqing Natural Science Foundation for Innovation Group Science Foundation

Zitieren

APA

Ye, J., Li, J., & Zhao, P. (2023). The Silkworm Carboxypeptidase Inhibitor Prevents Gastric Cancer Cells’ Proliferation through the EGF/EGFR Signaling Pathway. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms24021078

Vancouver

Ye J, Li J, Zhao P. The Silkworm Carboxypeptidase Inhibitor Prevents Gastric Cancer Cells’ Proliferation through the EGF/EGFR Signaling Pathway. International Journal of Molecular Sciences. 2023. doi:10.3390/ijms24021078

BibTeX
@article{Ye2023,
  author = {Ye, Junhong and Li, Jifu and Zhao, Ping},
  title = {The Silkworm Carboxypeptidase Inhibitor Prevents Gastric Cancer Cells’ Proliferation through the EGF/EGFR Signaling Pathway},
  journal = {International Journal of Molecular Sciences},
  year = {2023},
  doi = {10.3390/ijms24021078}
}
Kostenlos starten →